One-Year Graft Patency for Elective CABG Affected by Baseline Glycemic Control
Researchers assessed the relationship between 1-year vein graft patency, baseline hemoglobin A1c, and antiplatelet therapy in patients who have received CABG.
Researchers assessed the relationship between 1-year vein graft patency, baseline hemoglobin A1c, and antiplatelet therapy in patients who have received CABG.
A study was conducted to determine the effect of gender diversity in general cardiology on hospital readmission rates for multiple cardiovascular outcomes.
A study was conducted to determine 10-year outcomes for patients who have received either on- or off-pump coronary artery bypass grafting.
Investigators compared outcomes for coronary artery bypass grafting and drug-eluting stent implantation in patients with coronary artery disease.
Findings seen among patients with left ventricular ejection fraction >35 percent undergoing valve and/or coronary bypass surgery
Researchers compared PCI with CABG to determine the best revascularization strategy for patients with left main coronary artery disease.
Significantly lower rates of vein graft occlusion seen at three and 12 months for no-touch versus conventional vein harvesting.
This study assesses the risks and benefits of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy and whether they are modified by patients’ characteristics.
The researchers’ goals included quantifying and examining unplanned readmissions within 30 days of CABG surgery, including their causes and associated factors.
The researchers studied the Veterans Affairs data to evaluate the association of pre-operative hemoglobin A1c and long-term outcome after isolated coronary artery bypass grafting.